BEZ
NEUTRALBeazley Navigates Softening Markets in Q1 2025
The insurance provider navigates softening markets in the first quarter, reporting low premium growth amid subdued capital markets activity.
Beazley
882.50GBX
0.28%
Market Cap
5.63B
Volume
246.73k
10% of avg
P/E Ratio
7.95
EPS (TTM)
1.11
Beta
0.48
Day Range
872.00p - 885.50p
52 Week Range
611.00p882.50p944.50p
882.50p
Upcoming Events
BEZ
NEUTRALBeazley Appoints Non-Executive Director to Admiral Group Risk Committee
The insurance company has announced the appointment of an independent non-executive director to the Risk Committee of another firm.
BEZ
NEUTRALBeazley Announces Annual General Meeting Details
The insurance company has announced details for its upcoming Annual General Meeting, including the date, time, and location.
BEZ
NEUTRALBeazley Grants Share Incentives to Directors
The insurance company has granted share incentives to two of its directors as part of their remuneration packages.
BEZ
NEUTRALBeazley Director Exercises Share Awards
The insurance company announced a director has exercised share awards, with details on the number of shares vested and sold.
BEZ
GOODBeazley Announces £500 Million Share Buyback Programme
The insurance company announces a £500 million share buyback programme, signaling confidence in its future outlook.
BEZ
NEUTRALBeazley plc Reports Record Profit, Announces Dividend Hike and Share Buyback
The specialty insurer reported record profits and announced a significant dividend increase and share buyback program. However, cautious guidance and mentions of market headwinds suggest potential challenges ahead.
BEZ
NEUTRALBeazley Announces 2024 Year-End Results Release Date
The insurance company announces the date for its 2024 year-end results release and webcast.
BEZ
NEUTRALBeazley Grants Share Options to Director
Specialist insurance provider Beazley grants share options to director as part of long-term incentive plan.
BEZ
GOODBeazley Director Acquires Shares Amid Positive Broker Outlook
Specialist insurance company Beazley sees director buy shares, amid positive broker views.